Introduction: Imatinib is the treatment of choice in patients with locally advanced or metastatic
gastrointestinal stromal tumours (GIST). Clinical tolerance of imatinib is excellent except for
the common adverse drug reaction (ADR). Drug rash with eosinophilia and systemic symptoms
(DRESS syndrome) is a severe, potentially life-threatening drug-induced hypersensitivity reaction,
characterized by cutaneous eruptions, fever, diffuse lymphadenopathy, along with eosinophilia, and
elevated liver function tests. This ADR is rarely reported with imatinib. Only four cases of DRESS
syndrome associated with imatinib have already been published.
Case Report: We report an exceptional case of DRESS syndrome associated with imatinib in a 46
year-old woman with GIST. Two weeks after she had started imatinib therapy, she developed a skin
rash, with eosinophilia and elevated liver tests. Plasma level of imatinib was within the therapeutic
range. Imatinib was immediately discontinued. A favourable outcome was slowly observed after the
drug had been stopped. This case was scored three according to the European Registry of Severe Cutaneous
Adverse Reactions Study Group (RegiSCAR). The Naranjo score for imatinib was five (probable).